Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
FDA is urged to increase regulatory oversight over tanning beds
The American Cancer Society is calling on federal officials to subject tanning beds to greater FDA oversight due to findings that the devices are associated with an increased risk of skin cancer. Makers of tanning beds contend there has been no proof of a link between their products and fatal cancers.
Or we can send an email on your behalf